Logo-bi
Bioimpacts. 2025;15: 26443 | Published on: 2024 Apr 22. doi: 10.34172/bi.2023.26443
PMID: 39963556        PMCID: PMC11830123

Original Article

Mosaic vaccine design targeting mutational spike protein of SARS- CoV-2: An immunoinformatics approach

Ysrafil Ysrafil 1 ORCID, Arlan K. Imran 2, Prisca Syafriani Wicita 2, Vyani Kamba 2, Fihrina Mohamad 2, Ismail Ismail 3, Ayyub Harly Nurung 4, Noviyanty Indjar Gama 5, Sari Eka Pratiwi 6, Indwiani Astuti 7 ORCID, Firzan Nainu 8, Talha Bin Emran 9

Cited by CrossRef: 2

1- Nugraha M, Changestu D, Ramadhan R, Salsabila T, Nurizati A, Pratiwi S, Ysrafil Y. Novel prophylactic and therapeutic multi-epitope vaccine based on Ag85A, Ag85B, ESAT-6, and CFP-10 of Mycobacterium tuberculosis using an immunoinformatics approach. PHRP. 2024;15(4):286 [Crossref]
2- Ryan N, Pratiwi S, Mardhia M, Ysrafil Y, Liana D, Mahyarudin M. Immunoinformatics approach for design novel multi-epitope prophylactic and therapeutic vaccine based on capsid proteins L1 and L2 and oncoproteins E6 and E7 of human papillomavirus 16 and human papillomavirus 18 against cervical cancer. PHRP. 2024;15(4):307 [Crossref]

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 20% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons